Source: Circulation. Conference titles: 2017 AHA Late-Breaking Sciences Abstracts. Unidade: FM
Subjects: SÍNDROME CORONARIANA AGUDA, PLAQUETAS SANGUÍNEAS, CONDUTAS TERAPÊUTICAS
ABNT
ROE, Matthew T et al. P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1161/CIR.0000000000000546. Acesso em: 01 out. 2024. , 2017APA
Roe, M. T., Ohman, E. M., Povsic, T. J., White, J., Rockold, F., Montalescot, G., et al. (2017). P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes. Circulation. Dallas: Faculdade de Medicina, Universidade de São Paulo. doi:10.1161/CIR.0000000000000546NLM
Roe MT, Ohman EM, Povsic TJ, White J, Rockold F, Montalescot G, Cornel JH, Nicolau JC, Steg PG, Gibson CM. P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes [Internet]. Circulation. 2017 ; 136( 24): e458-e459.[citado 2024 out. 01 ] Available from: https://doi.org/10.1161/CIR.0000000000000546Vancouver
Roe MT, Ohman EM, Povsic TJ, White J, Rockold F, Montalescot G, Cornel JH, Nicolau JC, Steg PG, Gibson CM. P2Y12 inhibitor switching in response to routine notification of CYP2C19 clopidogrel metabolizer status following acute coronary syndromes [Internet]. Circulation. 2017 ; 136( 24): e458-e459.[citado 2024 out. 01 ] Available from: https://doi.org/10.1161/CIR.0000000000000546